Mannkind's Afrezza Facebook page gets slapped by FDA's promo police
Mannkind is in hot water for its Afrezza Facebook page. The FDA's Office of Prescription Drug Promotion chastised the pharma for failing to mention the inhaled insulin's risks, citing claims that included Afrezza "will help your body work its best and protect you from health complications" with "no drama."
17 Oct 2018 ... Mannkind is in hot water for its Afrezza Facebook page. The FDA's Office of Prescription Drug Promotion chastised the pharma for failing to ...